Overview of the clinical evidence for the use of NovaMin® in providing relief from the pain of dentin hypersensitivity

Journal of Clinical Dentistry

Volumn 22, Issue 3, 2011, Pages 90-95

  Gendreau, Linda ^a   Barlow, Ashley P S ^a   Mason, Stephen C ^a  

^a GlaxoSmithKline Consumer Healthcare ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICARIES AGENT; CALCIUM PHOSPHATE; DESENSITIZING AGENT; FLUORIDE; FLUOROPHOSPHATE; GLASS; HYDROXYAPATITE; NOVAMIN; PHOSPHATE; RHENANITE; SILICATE; TOOTHPASTE;

CHEMISTRY; DENTIN; DENTIN SENSITIVITY; DRUG EFFECT; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; ULTRASTRUCTURE;

CALCIUM PHOSPHATES; CARIOSTATIC AGENTS; DENTIN; DENTIN DESENSITIZING AGENTS; DENTIN SENSITIVITY; DURAPATITE; FLUORIDES; GLASS; HUMANS; PHOSPHATES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SILICATES; TOOTHPASTES; TREATMENT OUTCOME;

EID: 80155136926     PISSN: 08958831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R. Guidelines for the design and conduct of clinical trials on dentin hypersensitivity. J Clin Periodontal 1997;24:808-13. (Pubitemid 127731629)
2. Addy M. Dentin hypersensitivity: definition, prevalence, distribution and aetiology. In: Tooth Wear and Sensitivity, Addy M, Embery G, Edgar WM, Orchardson R, eds. Martin Dunitz Ltd., London, pp. 239-245,2000.
3. Addy M, Pearce N. Aetiological, predisposing and environmental factors in dentin hypersensitivity. Arch Oral Biol 1994;39(Suppl):S33-8. (Pubitemid 124007929)
4. Absi EG, Addy M, Adams D. Dentin hypersensitivity: a study of the patency of dentinal tubules in sensitive dentin. J Clin Periodontal 1987;14:280-4.
5. Gysi A. An attempt to explain the sensitiveness of dentin. Br J Dent Sci 1900;43:865-8.
6. Brannstrom M, Johnson G. Movements of the dentin and pulp liquids on application of thermal stimuli. An in vitro study. Acta Odontol Scand 1970; 28:59-70.
7. Addy M. Dentin hypersensitivity: new perspective on an old problem. Int Dent J 2002;52(Suppl):367-75.
8. Linde A, Goldberg M. Dentinogenesis. Crit Rev Oral Biol Med 1993;4: 679-728. (Pubitemid 24005050)
9. Cox CF, White KC, Ramus DL, Farmer JB, Snuggs HM. Reparative dentin: factors affecting its deposition. Quintessence Int 1992;23:257-70.
10. Magloire H, Bouvier M, Joffre A. Odontoblast response under carious lesions. Proc Finn Dent Soc 1992;88(Suppl):257-74.
11. D'Souza RN, Bachman T, Baumgardner KR, Butler WT, Litz M. Characterization of cellular responses involved in reparative dentinogenesis in rat molars. J Dent Res 1995;74:702-9.
12. Pulp-Dentin Biology in Restorative Dentistry, Mjör 1A, ed. Quintessence Publishing, pp. 77-85,2002.
13. Markowitz K, Pashley DH. Personal reflections on a sensitive subject. J Dent Res 2007;86:292-5.
14. Greenspan DS. NovaMin and tooth sensitivity- an overview. J Clin Dent 2010;21(SpecIss):61-5.
15. Zhong JP, LaTorre GP, Hench LL. The kinetics of bioactive ceramics Part VII: Binding of collagen to hydroxyapatite and bioactive glass. Proceedings of the 7th International Symposium on Ceramics in Medicine, Turku, Finland. In: Bioceramics 7th Ed. Andersson OH, and Yli-Urpo A, eds, pp. 61- 6,1994.
16. Efflandt SE, Magne P, Douglas WH, Francis LF. Interaction between bioactive glasses and human dentin. J Mater Sci Mater Med 2002;26:557-65. (Pubitemid 34533809)
17. Litkowski LJ, Hack GD, Sheaffer HB, Greenspan DC. Occlusion of dentin tubules by 45S5 Bioglass. Bioceramics 1997;10:411-14.
18. Burwell A, Jennings D, Muscle D, Greenspan DC. NovaMin and dentin hypersensitivity-in vitro evidence of efficacy. J Clin Dent 2010;21(Spec Iss):66-71.
19. LaTorre G, Greenspan DC. The role of ionic release from NovaMin (calcium sodium phosphosilicate) in tubule occlusion: an exploratory in vitro study using radio-labeled isotopes. J Clin Dent 2010;21 (Spec Iss):72-6.
20. Litkowski LJ, Greenspan DC. A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity-proof of principle. J Clin Dent 2010;21 (Spec Iss):77-81.
21. Earl JS, Leary RK, Muller KH, Langford RM, Greenspan DC. Physical and chemical characterization of dentin surface following treatment with NovaMin technology. J Clin Dent 2011;22(Spec Iss):62-67.
22. Earl JS, Topping N, Elle J, Langford RM, Greenspan DC. Physical and chemical characterization of the surface layers formed on dentin following treatment with a fluoridated toothpaste containing NovaMin. J Clin Dent 2011;22(SpecIss):68-73.
23. Parkinson CR, Willson RJ. A comparative in vitro study investigating the occlusion and mineralization properties of commercial toothpastes in a four-day dentin disc model. J Clin Dent 2011 ;22(Spec Iss):74-81.
24. West NX, Macdonald EL, Jones SB, Claydon NCA, Hughes N, Jeffery P. Randomized in situ clinical study comparing the ability of two new desensitizing toothpaste technologies to occlude patent dentin tubules. J Clin Dent 2011;22(SpecIss):82-89.
25. Du Min Q, Bian Z, Jiang H, Greenspan DC, Burwell AK, Zhong J, Tia BJ. Clinical evaluation of a dentifrice containing calcium sodium phosphosilicate (novamin) for the treatment of dentin hypersensitivity. Am J Dent 2008;21: 210-4.
26. Orchardson R. Strategies for the management of dentin hypersensitivity In: Tooth Wear and Sensitivity, Addy M, Embery G, Edgar WM, Orchardson R, eds. Martin Dunitz, Ltd., London, pp. 315-25,2000.
27. Clark GE, Troullos ES. Designing hypersensitivity clinical studies. Dent Clin North Am 1990;34:531-44.
28. Salian S, Thakur S, Kulkarni S, LaTorre G. A randomized, controlled clinical study evaluating the efficacy of two desensitizing dentifrices. J Clin Dent 2010;21(SpecIss):82-87.
29. Pradeep AR, Sharma A. Comparison of the clinical efficacy of a dentifrice containing calcium phosphosilicate with a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: a randomized clinical trial. 7 Periodontal 2010;81:1167-73.
30. Sharma N, Roy S, Kakar A, Greenspan DC, Scott R. A clinical study comparing oral formulations containing 7.5% calcium sodium phosphosilicate (NovaMin), 5% potassium nitrate and 0.4% stannous fluoride for the management of dentin hypersensitivity. J Clin Dent 2010;21(Spec Iss):88-92.
31. Clinical Study Report Z3690811. A clinical study to evaluate the efficacy of two toothpastes for the treatment of dentin hypersensitivity. Data on file (GSK),2011.
32. Narongdej T, Sakoolnamarka R, Boonroung T. The effectiveness of a calcium sodium phosphosilicate desensitizer in reducing cervical dentin hypersensitivity: a pilot study. J Am Dent Assoc 2010;141:995-9.